News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
662,731 Results
Type
Article (50958)
Company Profile (596)
Press Release (611177)
Multimedia
Podcasts (85)
Webinars (12)
Section
Business (184813)
Career Advice (2529)
Deals (33425)
Drug Delivery (122)
Drug Development (79349)
Employer Resources (155)
FDA (17279)
Job Trends (14725)
News (325465)
Policy (34926)
Tag
Academia (2704)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (87)
Alliances (48717)
ALS (94)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (141)
Approvals (17264)
Artificial intelligence (296)
Autoimmune disease (26)
Automation (16)
Bankruptcy (324)
Best Places to Work (11618)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (407)
Bladder cancer (76)
Brain cancer (30)
Breast cancer (274)
Cancer (2254)
Cardiovascular disease (191)
Career advice (2119)
Career pathing (31)
CAR-T (153)
Cell therapy (428)
Cervical cancer (20)
Clinical research (64600)
Collaboration (849)
Compensation (403)
Complete response letters (29)
COVID-19 (2748)
CRISPR (45)
C-suite (236)
Cystic fibrosis (100)
Data (2148)
Decentralized trials (2)
Denatured (21)
Depression (49)
Diabetes (286)
Diagnostics (6351)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (40)
Drug discovery (136)
Drug pricing (123)
Drug shortages (32)
Duchenne muscular dystrophy (97)
Earnings (73162)
Editorial (43)
Employer branding (18)
Employer resources (138)
Events (94806)
Executive appointments (680)
FDA (18586)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (754)
Gene editing (108)
Generative AI (30)
Gene therapy (321)
GLP-1 (790)
Government (4760)
Grass and pollen (4)
Guidances (61)
Healthcare (18114)
Huntington's disease (23)
IgA nephropathy (30)
Immunology and inflammation (122)
Indications (28)
Infectious disease (2903)
Inflammatory bowel disease (142)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (101)
Interviews (458)
IPO (15432)
IRA (47)
Job creations (3609)
Job search strategy (1776)
Kidney cancer (9)
Labor market (33)
Layoffs (465)
Leadership (23)
Legal (8223)
Liver cancer (74)
Lung cancer (320)
Lymphoma (151)
Machine learning (7)
Management (55)
Manufacturing (329)
MASH (67)
Medical device (13242)
Medtech (13247)
Mergers & acquisitions (18536)
Metabolic disorders (741)
Multiple sclerosis (84)
NASH (20)
Neurodegenerative disease (98)
Neuropsychiatric disorders (30)
Neuroscience (1948)
NextGen: Class of 2025 (6627)
Non-profit (4393)
Now hiring (26)
Obesity (400)
Opinion (258)
Ovarian cancer (76)
Pain (97)
Pancreatic cancer (78)
Parkinson's disease (149)
Partnered (21)
Patents (247)
Patient recruitment (110)
Peanut (50)
People (52289)
Pharmaceutical (128)
Pharmacy benefit managers (21)
Phase I (19919)
Phase II (28042)
Phase III (21640)
Pipeline (1202)
Policy (158)
Postmarket research (2709)
Preclinical (8261)
Press Release (70)
Prostate cancer (109)
Psychedelics (31)
Radiopharmaceuticals (248)
Rare diseases (396)
Real estate (5652)
Recruiting (61)
Regulatory (24173)
Reports (36)
Research institute (2435)
Resumes & cover letters (416)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (74)
Series A (132)
Series B (85)
Service/supplier (25)
Sickle cell disease (54)
Special edition (18)
Spinal muscular atrophy (154)
Sponsored (32)
Startups (3525)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (44)
The Weekly (62)
Vaccines (761)
Venture capitalists (38)
Weight loss (285)
Women's health (29)
Worklife (17)
Date
Today (160)
Last 7 days (820)
Last 30 days (2601)
Last 365 days (32633)
2025 (10592)
2024 (34717)
2023 (38973)
2022 (49870)
2021 (54060)
2020 (52991)
2019 (45844)
2018 (35238)
2017 (33005)
2016 (31929)
2015 (36552)
2014 (28900)
2013 (24286)
2012 (26034)
2011 (26522)
2010 (24099)
Location
Africa (905)
Alabama (50)
Alaska (7)
Arizona (173)
Arkansas (13)
Asia (41745)
Australia (6927)
California (5816)
Canada (1899)
China (524)
Colorado (259)
Connecticut (272)
Delaware (146)
Europe (91886)
Florida (883)
Georgia (208)
Hawaii (1)
Idaho (52)
Illinois (525)
India (28)
Indiana (294)
Iowa (12)
Japan (164)
Kansas (97)
Kentucky (25)
Louisiana (13)
Maine (54)
Maryland (902)
Massachusetts (4386)
Michigan (192)
Minnesota (362)
Mississippi (1)
Missouri (89)
Montana (26)
Nebraska (24)
Nevada (55)
New Hampshire (67)
New Jersey (1732)
New Mexico (29)
New York (1655)
North Carolina (951)
North Dakota (8)
Northern California (2433)
Ohio (194)
Oklahoma (11)
Oregon (41)
Pennsylvania (1270)
Puerto Rico (13)
Rhode Island (33)
South America (1224)
South Carolina (21)
South Dakota (1)
Southern California (2201)
Tennessee (93)
Texas (858)
United States (22163)
Utah (169)
Virginia (157)
Washington D.C. (63)
Washington State (542)
West Virginia (2)
Wisconsin (64)
662,731 Results for "astellas pharma us".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
With Pharma Throwing Billions At US Manufacturing, Where Is The Cash Going?
Major pharmaceutical companies are committing billions to US manufacturing in an effort to avoid steep tariffs threatened by President Donald Trump.
April 29, 2025
·
2 min read
·
Annalee Armstrong
Tariffs
J&J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing
In the company’s first-quarter earnings call Tuesday, J&J CEO Joaquin Duato said there’s a better way to encourage drug manufacturing in the U.S. than President Donald Trump’s threatened pharma tariffs.
April 15, 2025
·
3 min read
·
Annalee Armstrong
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
Playing both sides of trade war, pharma companies are asking for certain compensations for scientific innovation and a smoother regulatory framework.
April 16, 2025
·
2 min read
·
Tristan Manalac
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Manufacturing
J&J Joins Pharma Peers With $55B US Manufacturing Boost Following Trump’s Tariff Threats
Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major tariffs on pharmaceutical products. Pfizer has also promised a similar commitment.
March 21, 2025
·
2 min read
·
Annalee Armstrong
Tariffs
Trump Opens National Security Probe on Pharma Imports, Signaling Imminent Tariffs
Trump could use the findings of the probe to impose certain trade restrictions on pharma products, including tariffs.
April 15, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Trump Tariff Pause Sparks Late-Day Rally for Pharma Stocks—But Not All
Pharma stocks went on a wild ride Wednesday amid whiplashing tariff threats from the U.S. president.
April 10, 2025
·
2 min read
·
Annalee Armstrong
Manufacturing
Roche, Regeneron Pledge Multibillion Boosts to US Manufacturing as Trump’s Tariffs Loom
Roche is committing $50 billion while Regeneron inked a $3 billion manufacturing deal with Fujifilm, allowing the pharma to “nearly double” its U.S. large-scale manufacturing capacity.
April 22, 2025
·
2 min read
·
Tristan Manalac
BioMidwest
Astellas Names Michael Petroutsas as Head of US Commercial
Astellas Pharma Inc. Chief Commercial Officer Claus Zieler has named Michael Petroutsas as Head, United States Commercial, leading the Astellas Pharma US Inc. organization.
February 22, 2024
·
2 min read
1 of 66,274
Next
